Pure Global AI
Manufacturer profile

GOLDSITE DIAGNOSTICS INC

BrazilChina11 ANVISA registrations7 unique technical categoriesFeb 09, 2026 – Jul 06, 2026
Verified
11
Total products
7
Technical names
Feb 2026
Earliest registration
Jul 2026
Latest registration
Regulatory footprint
Search GOLDSITE DIAGNOSTICS INC across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this manufacturer
Instrument for chromatography analysis
GSH-50 Automatic HPLC HbA1c Analyzer
Class II · Jul 06, 2026
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
Tampão de Eluição de HbA1c A GSH-60
Class I · Mar 09, 2026
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
Tampão de Eluição de HbA1c B GSH-60
Class I · Mar 09, 2026
GLYCATED HEMOGLOBIN (HbA1C)
Família Calibradores e Controles de HbA1c GSH-60
Class II · Mar 09, 2026
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
Tampão de Eluição de HbA1c C GSH-60
Class I · Mar 09, 2026
Most popular products
Products with most registrations
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
3 registrations
Instrument for chromatography analysis
2 registrations
GLYCATED HEMOGLOBIN (HbA1C)
2 registrations
LYSIS SOLUTION
1 registrations
SERUM AMYLOID A PROTEIN (SAA)
1 registrations
Top registration holders
Companies holding product registrations for this manufacturer
PRODIGY COMPANY LTDA
7 products
HOPE PHARMA LTDA
4 products
Top competitors
Companies with the most overlapping products (same technical names)
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
China
97 registrations6 shared products
Shared products
C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrument for chromatography analysis, LYSIS SOLUTION, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
ZYBIO INC.
China
52 registrations6 shared products
Shared products
C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, LYSIS SOLUTION, SERUM AMYLOID A PROTEIN (SAA), TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD
China
40 registrations6 shared products
Shared products
C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, LYSIS SOLUTION, SERUM AMYLOID A PROTEIN (SAA), TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
DIRUI INDUSTRIAL CO. LTD
China
33 registrations6 shared products
Shared products
C-REACTIVE PROTEIN, Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrumento para análise de bioquímica geral, hormônios, drogas ou proteínas, LYSIS SOLUTION, SERUM AMYLOID A PROTEIN (SAA), TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
IN VITRO DIAGNOSTICA LTDA
Brazil
33 registrations6 shared products
Shared products
C-REACTIVE PROTEIN, GLYCATED HEMOGLOBIN (HbA1C), Instrument for analysis of general biochemistry, hormones, drugs or proteins, Instrument for chromatography analysis, LYSIS SOLUTION, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
About this profile

Explore comprehensive manufacturer profile for GOLDSITE DIAGNOSTICS INC based in China through Pure Global AI's free Brazil medical device database. This manufacturer has 11 products registered with ANVISA across 7 unique technical categories. Their regulatory history spans from Feb 09, 2026 to Jul 06, 2026.

This page provides detailed insights including 5 recent product registrations including Instrument for chromatography analysis, 5 most popular products with TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL having 3 registrations, 2 registration holders including PRODIGY COMPANY LTDA, and 5 key competitors with SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD sharing 6 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.